Alpha1-adrenergic blockade and sudden cardiac death

E. Vanoli, S. S. Hull, R. D. Foreman, A. Ferrari, P. J. Schwartz

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Alpha1-Adrenergic Blockade and Sudden Cardiac Death. Introduction: The primary goal of the present study was to test whether selective pharmacologic blockade of alpha1 receptors, and specifically of the subtype alpha(1a), could prevent ventricular fibrillation (VF) during acute myocardial ischemia. Background: The development of new autonomic interventions is of clinical interest in view of the failure of traditional antiarrhythmic drugs to prevent sudden death. Experimental evidence indicates that alpha1 receptors, and in particular the subtype alpha(1a), may be involved in the genesis of malignant arrhythmias during acute myocardial ischemia and reperfusion. Despite this evidence, questions have been raised about the actual antifibrillatory efficacy of alpha-adrenergic blockade in the acutely ischemic myocardium. The effects of prazosin and of abanoquil (UK 52,046), a highly selective alpha(1a) receptor blocker, were tested and compared with propranolol in a conscious animal preparation for sudden death. Methods and Results: Ten dogs with a 1-month-old anterior wall myocardial infarction were studied. These dogs had all developed, in control conditions, VF during a 2- minute occlusion of the circumflex coronary artery while exercising (n = 9) or lying on the table (n = 1). Afterwards, the dogs underwent additional tests with the following intravenously administered drugs: abanoquil (n = 10; 1 μg/kg), prazosin (n = 9; 0.1 mg/kg), and propranolol (n = 10; 1 mg/kg). Internal control analysis was used. All dogs tested had recurrence of VF with both alpha-adrenergic blockers. Propranolol significantly reduced heart rate during ischemia and prevented VF in 5 of 10 dogs tested (P <0.05). When heart rate was kept constant by atrial pacing (n = 3), 2 of the 3 animals remained protected by propranolol. Just prior to onset of VF, heart rate was not significantly different in the control and in the abanoquil tests (237 ± 45 and 253 ± 34 beats/min, respectively), whereas it was higher (P <0.05) with prazosin (288 ± 40 beats/min). Conclusions: Alpha1 and alpha(1a) receptor blockers do not prevent VF secondary to acute myocardial ischemia in the presence of elevated sympathetic activity and heart rate. In the same setting, beta-adrenergic blockade prevents the reflex heart rate increase due to ischemia and provides a significant protection.

Original languageEnglish
Pages (from-to)76-89
Number of pages14
JournalJournal of Cardiovascular Electrophysiology
Volume5
Issue number1
Publication statusPublished - 1994

Fingerprint

Sudden Cardiac Death
Ventricular Fibrillation
Adrenergic Agents
Propranolol
Heart Rate
Dogs
Prazosin
Myocardial Ischemia
Sudden Death
Ischemia
Anterior Wall Myocardial Infarction
Adrenergic alpha-Antagonists
Myocardial Reperfusion
Anti-Arrhythmia Agents
Reflex
Cardiac Arrhythmias
Coronary Vessels
Myocardium
Recurrence
abanoquil

Keywords

  • alpha-adrenergic blockade
  • sudden cardiac death

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Alpha1-adrenergic blockade and sudden cardiac death. / Vanoli, E.; Hull, S. S.; Foreman, R. D.; Ferrari, A.; Schwartz, P. J.

In: Journal of Cardiovascular Electrophysiology, Vol. 5, No. 1, 1994, p. 76-89.

Research output: Contribution to journalArticle

Vanoli, E. ; Hull, S. S. ; Foreman, R. D. ; Ferrari, A. ; Schwartz, P. J. / Alpha1-adrenergic blockade and sudden cardiac death. In: Journal of Cardiovascular Electrophysiology. 1994 ; Vol. 5, No. 1. pp. 76-89.
@article{890ab9aa8eee42d3ae1023e139a8c2ae,
title = "Alpha1-adrenergic blockade and sudden cardiac death",
abstract = "Alpha1-Adrenergic Blockade and Sudden Cardiac Death. Introduction: The primary goal of the present study was to test whether selective pharmacologic blockade of alpha1 receptors, and specifically of the subtype alpha(1a), could prevent ventricular fibrillation (VF) during acute myocardial ischemia. Background: The development of new autonomic interventions is of clinical interest in view of the failure of traditional antiarrhythmic drugs to prevent sudden death. Experimental evidence indicates that alpha1 receptors, and in particular the subtype alpha(1a), may be involved in the genesis of malignant arrhythmias during acute myocardial ischemia and reperfusion. Despite this evidence, questions have been raised about the actual antifibrillatory efficacy of alpha-adrenergic blockade in the acutely ischemic myocardium. The effects of prazosin and of abanoquil (UK 52,046), a highly selective alpha(1a) receptor blocker, were tested and compared with propranolol in a conscious animal preparation for sudden death. Methods and Results: Ten dogs with a 1-month-old anterior wall myocardial infarction were studied. These dogs had all developed, in control conditions, VF during a 2- minute occlusion of the circumflex coronary artery while exercising (n = 9) or lying on the table (n = 1). Afterwards, the dogs underwent additional tests with the following intravenously administered drugs: abanoquil (n = 10; 1 μg/kg), prazosin (n = 9; 0.1 mg/kg), and propranolol (n = 10; 1 mg/kg). Internal control analysis was used. All dogs tested had recurrence of VF with both alpha-adrenergic blockers. Propranolol significantly reduced heart rate during ischemia and prevented VF in 5 of 10 dogs tested (P <0.05). When heart rate was kept constant by atrial pacing (n = 3), 2 of the 3 animals remained protected by propranolol. Just prior to onset of VF, heart rate was not significantly different in the control and in the abanoquil tests (237 ± 45 and 253 ± 34 beats/min, respectively), whereas it was higher (P <0.05) with prazosin (288 ± 40 beats/min). Conclusions: Alpha1 and alpha(1a) receptor blockers do not prevent VF secondary to acute myocardial ischemia in the presence of elevated sympathetic activity and heart rate. In the same setting, beta-adrenergic blockade prevents the reflex heart rate increase due to ischemia and provides a significant protection.",
keywords = "alpha-adrenergic blockade, sudden cardiac death",
author = "E. Vanoli and Hull, {S. S.} and Foreman, {R. D.} and A. Ferrari and Schwartz, {P. J.}",
year = "1994",
language = "English",
volume = "5",
pages = "76--89",
journal = "Journal of Cardiovascular Electrophysiology",
issn = "1045-3873",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Alpha1-adrenergic blockade and sudden cardiac death

AU - Vanoli, E.

AU - Hull, S. S.

AU - Foreman, R. D.

AU - Ferrari, A.

AU - Schwartz, P. J.

PY - 1994

Y1 - 1994

N2 - Alpha1-Adrenergic Blockade and Sudden Cardiac Death. Introduction: The primary goal of the present study was to test whether selective pharmacologic blockade of alpha1 receptors, and specifically of the subtype alpha(1a), could prevent ventricular fibrillation (VF) during acute myocardial ischemia. Background: The development of new autonomic interventions is of clinical interest in view of the failure of traditional antiarrhythmic drugs to prevent sudden death. Experimental evidence indicates that alpha1 receptors, and in particular the subtype alpha(1a), may be involved in the genesis of malignant arrhythmias during acute myocardial ischemia and reperfusion. Despite this evidence, questions have been raised about the actual antifibrillatory efficacy of alpha-adrenergic blockade in the acutely ischemic myocardium. The effects of prazosin and of abanoquil (UK 52,046), a highly selective alpha(1a) receptor blocker, were tested and compared with propranolol in a conscious animal preparation for sudden death. Methods and Results: Ten dogs with a 1-month-old anterior wall myocardial infarction were studied. These dogs had all developed, in control conditions, VF during a 2- minute occlusion of the circumflex coronary artery while exercising (n = 9) or lying on the table (n = 1). Afterwards, the dogs underwent additional tests with the following intravenously administered drugs: abanoquil (n = 10; 1 μg/kg), prazosin (n = 9; 0.1 mg/kg), and propranolol (n = 10; 1 mg/kg). Internal control analysis was used. All dogs tested had recurrence of VF with both alpha-adrenergic blockers. Propranolol significantly reduced heart rate during ischemia and prevented VF in 5 of 10 dogs tested (P <0.05). When heart rate was kept constant by atrial pacing (n = 3), 2 of the 3 animals remained protected by propranolol. Just prior to onset of VF, heart rate was not significantly different in the control and in the abanoquil tests (237 ± 45 and 253 ± 34 beats/min, respectively), whereas it was higher (P <0.05) with prazosin (288 ± 40 beats/min). Conclusions: Alpha1 and alpha(1a) receptor blockers do not prevent VF secondary to acute myocardial ischemia in the presence of elevated sympathetic activity and heart rate. In the same setting, beta-adrenergic blockade prevents the reflex heart rate increase due to ischemia and provides a significant protection.

AB - Alpha1-Adrenergic Blockade and Sudden Cardiac Death. Introduction: The primary goal of the present study was to test whether selective pharmacologic blockade of alpha1 receptors, and specifically of the subtype alpha(1a), could prevent ventricular fibrillation (VF) during acute myocardial ischemia. Background: The development of new autonomic interventions is of clinical interest in view of the failure of traditional antiarrhythmic drugs to prevent sudden death. Experimental evidence indicates that alpha1 receptors, and in particular the subtype alpha(1a), may be involved in the genesis of malignant arrhythmias during acute myocardial ischemia and reperfusion. Despite this evidence, questions have been raised about the actual antifibrillatory efficacy of alpha-adrenergic blockade in the acutely ischemic myocardium. The effects of prazosin and of abanoquil (UK 52,046), a highly selective alpha(1a) receptor blocker, were tested and compared with propranolol in a conscious animal preparation for sudden death. Methods and Results: Ten dogs with a 1-month-old anterior wall myocardial infarction were studied. These dogs had all developed, in control conditions, VF during a 2- minute occlusion of the circumflex coronary artery while exercising (n = 9) or lying on the table (n = 1). Afterwards, the dogs underwent additional tests with the following intravenously administered drugs: abanoquil (n = 10; 1 μg/kg), prazosin (n = 9; 0.1 mg/kg), and propranolol (n = 10; 1 mg/kg). Internal control analysis was used. All dogs tested had recurrence of VF with both alpha-adrenergic blockers. Propranolol significantly reduced heart rate during ischemia and prevented VF in 5 of 10 dogs tested (P <0.05). When heart rate was kept constant by atrial pacing (n = 3), 2 of the 3 animals remained protected by propranolol. Just prior to onset of VF, heart rate was not significantly different in the control and in the abanoquil tests (237 ± 45 and 253 ± 34 beats/min, respectively), whereas it was higher (P <0.05) with prazosin (288 ± 40 beats/min). Conclusions: Alpha1 and alpha(1a) receptor blockers do not prevent VF secondary to acute myocardial ischemia in the presence of elevated sympathetic activity and heart rate. In the same setting, beta-adrenergic blockade prevents the reflex heart rate increase due to ischemia and provides a significant protection.

KW - alpha-adrenergic blockade

KW - sudden cardiac death

UR - http://www.scopus.com/inward/record.url?scp=0028144226&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028144226&partnerID=8YFLogxK

M3 - Article

C2 - 7910510

AN - SCOPUS:0028144226

VL - 5

SP - 76

EP - 89

JO - Journal of Cardiovascular Electrophysiology

JF - Journal of Cardiovascular Electrophysiology

SN - 1045-3873

IS - 1

ER -